Eight healthy babies born with "three-person" mitochondrial donation IVF
Published · Researched 2026-09-22
What happened (dated facts)
On July 16, 2025, Newcastle University announced that eight babies — four girls and four boys, including one set of identical twins — had been born to seven women at high risk of transmitting serious mitochondrial DNA disease, using the licensed IVF technique of mitochondrial donation (pronuclear transfer). The findings were published in two papers in the New England Journal of Medicine. All eight babies were healthy at birth, are meeting their developmental milestones, and show no signs of mitochondrial DNA disease; the mothers' disease-causing mitochondrial mutations were undetectable or present at levels very unlikely to cause disease. The technique was pioneered by Newcastle University and the Newcastle upon Tyne Hospitals NHS Foundation Trust (funded by Wellcome and NHS England). By July 1, 2025, the UK's HFEA had approved 35 patients for the treatment on a case-by-case basis; only the Newcastle Fertility Centre at Life is licensed to provide it.
Why it is genuinely positive
Mitochondrial diseases are incurable and can kill babies within months — one campaigning family lost their daughter Lily at 8 months old in 2006. Eight families who faced the certainty of passing on a devastating disease now have healthy children hitting their milestones. It is a world-first reproductive medicine achievement: the UK remains the only country with a licensed pathway for it, and Australia has since changed its laws to follow.
Social pulse
Circulating on Threads: newsinfoandhub (Sept 15, 2026) — "UK regulators have confirmed the first babies born using DNA from three people. Most DNA comes from the parents, with about 0.1% from a donor woman to help prevent deadly mitochondrial diseases." Broad press coverage (AP via phys.org, July 2025). Patient-advocacy celebration: Mito Patients / The Lily Foundation (Liz Curtis MBE's campaigning was instrumental in the UK legal change).
Verified quotes
- "As parents, all we ever wanted was to give our child a healthy start in life. Mitochondrial donation IVF made that possible. After years of uncertainty, this treatment gave us hope — and then it gave us our baby. We look at them now, full of life and possibility, and we're overwhelmed with gratitude. Science gave us a chance." — Mother of a baby girl born via mitochondrial donation (Newcastle University press office, July 16, 2025).
- "We are now proud parents to a healthy baby — a true mitochondrial replacement success. This breakthrough has lifted the heavy cloud of fear that once loomed over us." — Mother of a baby boy born via mitochondrial donation (Newcastle University press office, July 16, 2025).
Verification
- Tier: 2
- Primary source: Newcastle University press office (July 16, 2025) + two NEJM papers. Proves: 8 healthy babies, 4 girls/4 boys incl. twins, 7 mothers, no signs of mitochondrial DNA disease, developmental milestones met, mutation levels undetectable or sub-clinical.
- Social sources: Threads — newsinfoandhub (Sept 15, 2026, "three-person DNA" explainer post); advocacy layer — Mito Patients / The Lily Foundation statements (July 2025). Proves: continued social circulation and community meaning beyond the announcement.
- Positivity check: healthy babies born to families facing incurable disease — with the honest caveats below stated, not hidden. Passed.
Key facts
| Fact | Value | Source | Date |
|---|---|---|---|
| Babies born | 8 (4 girls, 4 boys, incl. identical twins) to 7 women | Newcastle University | 2025-07-16 |
| Technique | Pronuclear transfer (mitochondrial donation); <0.1% donor DNA | Newcastle / karmactive | 2025-07-16 |
| Publication | Two papers, New England Journal of Medicine | Newcastle University | 2025-07-16 |
| Outcomes | All healthy at birth, milestones met, no signs of mtDNA disease | Newcastle University | 2025-07-16 |
| Treated cohort | 22 women treated → 8 babies + 1 ongoing pregnancy (~36% clinical pregnancy rate) | karmactive | 2025 |
| HFEA approvals | 35 patients approved case-by-case as of July 1, 2025 | karmactive | 2025-07-01 |
| Caveat 1 | One baby had infant myoclonic epilepsy (resolved spontaneously); another cardiac arrhythmia (responding to treatment) — not believed linked to therapy | karmactive / NEJM reporting | 2025 |
| Caveat 2 | 3 babies had up to 16% mutant mtDNA — below the 80% disease threshold | karmactive | 2025 |
UNVERIFIED points
- Long-term outcomes: the children are still young; lifelong follow-up is planned but not yet reported.
- The 36% clinical pregnancy rate and HFEA approval count come from a secondary source (karmactive), not the NEJM papers directly.
- No story-specific photos (Newcastle Fertility Centre/AP video stills) were returned by image search this session; banked locators are generic, flagged as such.